Related Experiment Video
Updated: Aug 5, 2026

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
Published on: January 27, 2018
Stable reduction of upper cervical spinal cord area in cervical dystonia
Melanie Suette1, Teresa Gerhalter1, Thiago J R Rezende2
1Department of Neurology, Medical University of Graz, Graz, Austria.
Background:
While cervical dystonia (CD) is predominantly viewed as a disorder of brain-based motor network dysfunction, chronic dystonic head and neck posturing may affect the upper cervical spinal cord, a structure that has been largely overlooked, partly due to the lack of imaging protocols optimized for the craniovertebral junction.
Objective:
To assess cross-sectional area (CA) and cord eccentricity (CE) of the upper cervical spinal cord at C1-C3 in patients with CD, compared with healthy controls (HC), and to examine their longitudinal stability over a period of 6.2 years.
Methods:
37 patients with CD and 38 age- and sex-matched HC underwent 3T MRI with T1-weighted structural brain imaging covering the upper cervical spinal cord (C1-C3). CA and CE at C1-C3 were quantified using an automated ENIGMA-based spinal cord pipeline. Cross-sectional group differences were tested and longitudinal change was evaluated in 26 patients re-imaged after a mean follow-up of 6.2 years (Range: 2.1 - 11.9).
Results:
Compared with HC, patients with CD exhibited significantly reduced CA at C2 (Mdiff = 3.49 mm2, p = .048) as well as at C3 (Mdiff = 4.07 mm2, p = .048), while CA at C1 and CE measures at all levels did not differ. No longitudinal decline of CA was observed in CD patients over a period of 6.2 years (Range: 2.1 - 11.9).
Conclusion:
CD is associated with stable reductions in upper CA at C2-C3 with no evidence of further decline over the observed follow-up period. These findings support the interpretation of a secondary structural adaptation related to chronic abnormal head-neck biomechanics, rather than a primary or progressive spinal cord pathology.
Related Concept Videos
Alterations in Muscle Tone ll
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Alterations in Muscle Tone lll
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...